Comparison of gene expression patterns amongLeishmania braziliensisclinical isolates showing a differentin vitrosusceptibility to pentavalent antimony
- 3 August 2010
- journal article
- research article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 138 (2) , 183-193
Abstract
SUMMARY: Introduction. Evaluation ofLeishmaniadrug susceptibility depends onin vitroSbVsusceptibility assays, which are labour-intensive and may give a biased view of the true parasite resistance. Molecular markers are urgently needed to improve and simplify the monitoring of SbV-resistance. We analysed here the gene expression profile of 21L. braziliensisclinical isolatesin vitrodefined as SbV-resistant and -sensitive, in order to identify potential resistance markers.Methods. The differential expression of 13 genes involved in SbVmetabolism, oxidative stress or housekeeping functions was analysed duringin vitropromastigote growth.Results. Expression profiles were up-regulated for 5 genes only, each time affecting a different set of isolates (mosaic picture of gene expression). Two genes,ODC(ornithine decarboxylase) andTRYR(trypanothione reductase), showed a significantly higher expression rate in the group of SbV-resistant compared to the group of SbV-sensitive parasites (PDiscussion. Our results might be explained by (i) the occurrence of a pleiotropic molecular mechanism leading to thein vitroSbVresistance and/or (ii) the existence of different epi-phenotypes not revealed by thein vitroSbVsusceptibility assays, but interfering with the gene expression patterns.Keywords
This publication has 33 references indexed in Scilit:
- Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomesInfection, Genetics and Evolution, 2010
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific DifferencesAntimicrobial Agents and Chemotherapy, 2009
- Testing significance relative to a fold-change threshold is a TREATBioinformatics, 2009
- Structure, dynamics and function of Leishmania genome: Resolving the puzzle of infection, genetics and evolution?Infection, Genetics and Evolution, 2008
- Comparative genomics: From genotype to disease phenotype in the leishmaniasesInternational Journal for Parasitology, 2007
- Comparative genomic analysis of three Leishmania species that cause diverse human diseaseNature Genetics, 2007
- Increased levels of thiols protect antimony unresponsiveLeishmania donovanifield isolates against reactive oxygen species generated by trivalent antimonyParasitology, 2007
- Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica ParasitesPLOS Medicine, 2006
- Advances in leishmaniasisThe Lancet, 2005
- An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovaniJournal of Antimicrobial Chemotherapy, 1984